Protease inhibitor therapy for recessive dystrophic epidermolysis bullosa. In vitro effect and clinical trial with camostat mesylate.

Source:http://linkedlifedata.com/resource/pubmed/id/3385039

Download in:

View as

General Info

PMID
3385039